Skip to content
lsd.com

Indication

Borderline Personality Disorder

3 registered trials testing Psilocybin, MDMA, Ketamine for this indication, 2 recruiting now.

Sponsors register this under 2 different names, all collected here: Borderline Personality Disorder · Borderline Personality Disorder (BPD)

3
Registered trials
2
Recruiting
0
In Phase 3

Substances tested

Being studied with

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Borderline Personality Disorder trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 3 trials for Borderline Personality Disorder

TrialStatusPhaseSubstanceSites
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)NCT07569198 · Joshua RosenblatRecruitingPhase 2ketamine1
MDMA in Borderline Personality DisorderNCT06683014 · Yale UniversityRecruitingPhase 2mdma1
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality DisorderNCT05399498 · University of ChicagoCompletedPhase 2psilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.